Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint BluePrint Breast Cancer Kit to Market
IRVINE, CA, AMSTERDAM, and RIJSWIJK, NETHERLANDS – 19 December 2017 Read More
IRVINE, CA, AMSTERDAM, and RIJSWIJK, NETHERLANDS – 19 December 2017 Read More
IRVINE, CA, AMSTERDAM, NETHERLANDS – 7 December 2017 – Agendia, Read More
Institut Curie is one of an increasing number of major Read More
IRVINE, CA, AMSTERDAM, NETHERLANDS – 30 November 2017 – Agendia, Read More
CMS established the 2018 payment rate for MammaPrint’s new CPT Read More
Update clarifies that the patient and clinician may choose any Read More
PUBLICATION: JAMA Oncol. 2017;3(11):1503-1510. doi:10.1001/jamaoncol.2017.1261. AUTHORS: Laura J. Esserman, MD, Read More
PUBLICATION: Breast Cancer Res Treat (2017) 166: 593. https://doi.org/10.1007/s10549-017-4428-9. AUTHORS: Read More
Prospective PROMIS trial showed no correlation between the two tests Read More